Arcturus Therapeutics Holdings, Inc. (ARCT)
11.27
+0.15
(+1.35%)
USD |
NASDAQ |
Oct 15, 16:00
11.26
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Cash from Operations (TTM) : -78.07M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -78.07M |
| March 31, 2026 | -63.07M |
| December 31, 2025 | -78.77M |
| September 30, 2025 | -61.15M |
| June 30, 2025 | -65.35M |
| March 31, 2025 | -89.27M |
| December 31, 2024 | -59.69M |
| September 30, 2024 | -59.78M |
| June 30, 2024 | -67.57M |
| March 31, 2024 | 12.85M |
| December 31, 2023 | -17.46M |
| September 30, 2023 | 138.25M |
| June 30, 2023 | 129.42M |
| March 31, 2023 | 43.97M |
| December 31, 2022 | 30.80M |
| September 30, 2022 | -169.51M |
| June 30, 2022 | -146.20M |
| March 31, 2022 | -144.38M |
| December 31, 2021 | -138.29M |
| September 30, 2021 | -100.54M |
| June 30, 2021 | -99.94M |
| March 31, 2021 | -75.33M |
| December 31, 2020 | -44.23M |
| September 30, 2020 | -44.53M |
| June 30, 2020 | -30.84M |
| Date | Value |
|---|---|
| March 31, 2020 | -13.02M |
| December 31, 2019 | -6.574M |
| September 30, 2019 | -4.366M |
| June 30, 2019 | -8.126M |
| March 31, 2019 | -25.20M |
| December 31, 2018 | -20.15M |
| September 30, 2018 | -4.562M |
| June 30, 2018 | 0.6337M |
| March 31, 2018 | 4.132M |
| December 31, 2017 | -0.4714M |
| September 30, 2017 | -14.48M |
| June 30, 2017 | -19.81M |
| March 31, 2017 | -19.81M |
| December 31, 2016 | -19.28M |
| September 30, 2016 | -19.54M |
| June 30, 2016 | -18.26M |
| March 31, 2016 | -18.03M |
| December 31, 2015 | -18.18M |
| September 30, 2015 | -20.05M |
| June 30, 2015 | -23.89M |
| March 31, 2015 | -25.43M |
| December 31, 2014 | -26.46M |
| September 30, 2014 | -25.45M |
| June 30, 2014 | -18.14M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Emergent BioSolutions, Inc. | 97.70M |
| Exelixis, Inc. | 1.183B |
| Ionis Pharmaceuticals, Inc. | -496.43M |
| United Therapeutics Corp. | 1.682B |